There are too few scientific studies in the world to evaluate the hypothesis of Rospotrebnadzor about the mild course of
COVID-19 in allergy sufferers, allergist-immunologist Vladimir Bolibok told RBC. According to him,
it is almost impossible to make an individual forecast. “There are many patients with allergic reactions, they get sick with COVID-19, some of them die. You have to be grafted. And...